Zumbro Discovery Overview

  • Founded
  • 2012
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Zumbro Discovery General Information


Developer of novel natriuretic peptide designed to provide treatment of cardiovascular and metabolic disease. The company's drug is used for the treatment of resistant hypertension which leads to heart failure, myocardial infarction, stroke, and kidney disease, thereby enabling hospitals to begin treatment quickly and have a higher chance of successful treatments.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Rochester, NY
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zumbro Discovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 00.00 Completed Out of Business
3. Early Stage VC 15-Sep-2017 00000 00.00 Completed Clinical Trials - Phase 1
2. Early Stage VC 01-Jun-2015 $300K $1.8M Completed Startup
1. Seed Round 01-Mar-2013 $1.5M $1.5M Completed Startup
To view Zumbro Discovery’s complete valuation and funding history, request access »

Zumbro Discovery Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of novel natriuretic peptide designed to provide treatment of cardiovascular and metabolic disease. The compan
Drug Discovery
Rochester, NY
000 00 00000 00.00


s aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Paris, France
0 As of 0000
000000000 00000


onsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut en
Lyon, France
000 As of 0000
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zumbro Discovery Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Quantum Genomics Corporation Paris, France 0 00000 000000000 00000
000000 Formerly VC-backed Lyon, France 000 000.00 00000000 000.00
00000 000000000000 Corporate Backed or Acquired Carlsbad, CA 000 0000 00000000000 0000
You’re viewing 3 of 3 competitors. Get the full list »